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ABSTRACT
RAD51, a eukaryotic recombinase, catalyzes
homologous-pairing and strand-exchange reac-
tions, which are essential steps in homologous
recombination and recombinational repair of
double strand breaks. On the other hand, human
PSF was originally identified as a component of
spliceosomes, and its multiple functions in RNA
processing, transcription and DNA recombination
were subsequently revealed. In the present study,
we found that PSF directly interacted with RAD51.
PSF significantly enhanced RAD51-mediated homol-
ogous pairing and strand exchange at low RAD51
concentrations; however, in contrast, it inhibited
these RAD51-mediated recombination reactions at
the optimal RAD51 concentration. Deletion analyses
revealed that the N-terminal region of PSF pos-
sessed the RAD51- and DNA-binding activities, but
the central region containing the RNA-recognition
motifs bound neither RAD51 nor DNA. These results
suggest that PSF may have dual functions in homol-
ogous recombination and RNA processing through
its N-terminal and central regions, respectively.
INTRODUCTION
Homologous recombination functions in accurate chro-
mosome segregation during meiotic cell division I (1,2).
Defects in meiotic homologous recombination in mice
cause infertility, indicating its required function in meiosis
(3–5). Homologous recombination also has essential func-
tions in the repair of DNA double strand breaks (DSBs)
and the rescue of stalled replication forks during mitosis
(6–8). The homologous-recombination defects in mitosis
cause instability of the genomic DNA (8,9), leading to
chromosomal aberrations and tumorigenesis. Therefore,
homologous recombination is essential for both meiotic
and mitotic cell divisions.
RAD51, a eukaryotic homologue of bacterial RecA, is a
central DNA recombinase, which functions in both
meiotic and mitotic homologous recombination (10).
During the homologous-recombination process, RAD51
promotes the key recombination reactions, homologous
pairing and strand exchange, in an ATP-dependent
manner (11–15). To promote homologous pairing,
RAD51 ﬁrst binds to single-stranded DNA (ssDNA),
which is produced at the DSB site, and forms helical
nucleoprotein ﬁlaments. The RAD51–ssDNA ﬁlaments
then bind to intact double-stranded DNA (dsDNA). The
homologous sequences are aligned between ssDNA and
dsDNA, and new Watson–Crick base pairs (heteroduplex)
are formed between the ssDNA and the complementary
strand of the dsDNA within the RAD51–ssDNA–dsDNA
ﬁlament. This step is called homologous pairing. The
heteroduplex region formed by homologous pairing is fur-
ther expanded by the RAD51-mediated strand exchange
reaction. RAD51 requires cofactors for eﬃcient promo-
tion of the homologous-pairing and strand-exchange
reactions. In humans, RAD52, RAD54, RAD54B,
RAD51B–RAD51C, RAD51AP1 and BRCA2 have been
reported as such cofactors for the RAD51-mediated
homologous pairing and/or strand exchange reactions
in vitro (7–10,16–18).
Polypyrimidine tract-binding protein-associated splicing
factor (PSF) was ﬁrst identiﬁed as a component of the
spliceosome (19). A tandem repeat of RNA-recognition
motifs was found in the central region of PSF,
suggesting that PSF functions in RNA processing through
its RNA-binding activity. Subsequently, the DNA-bind-
ing activity of PSF and its regulatory function for tran-
scription were reported (20–24). PSF was also identiﬁed
in a complex form with its paralog, p54(nrb). The PSF–
p54(nrb) complex reportedly binds to mRNAs, and func-
tions in pre-mRNA processing (25,26). A biochemical
study revealed that the PSF–p54(nrb) complex also sti-
mulates the DNA end joining reaction by Ku70/80,
DNA ligase IV and XRCC4 (27). These facts suggest
that PSF may be a multifunctional protein, which func-
tions in RNA processing, transcription regulation and
DNA recombination.
Interestingly, PSF alone reportedly promotes homolo-
gous pairing between ssDNA and dsDNA in vitro (28),
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recombination. To evaluate the functions of PSF in
homologous recombination, in the present study, we
tested whether PSF aﬀects the recombination reactions
promoted by RAD51, which is an essential recombinase
in both meiotic and mitotic homologous recombination.
We found that puriﬁed human PSF directly binds to
RAD51. Biochemical analyses revealed that PSF synergis-
tically stimulates RAD51-mediated homologous pairing
and strand exchange under low RAD51 conditions. In
contrast, the RAD51-mediated recombination reactions
were signiﬁcantly inhibited by PSF, when the RAD51 con-
centrations were optimal for the homologous-pairing and
strand-exchange reactions without PSF. Domain mapping
analyses showed that the N-terminal region (amino acid
residues 1–266) of PSF and the central ATPase domain
(amino acid residues 82–339) of RAD51 are involved
in the PSF–RAD51 binding. The PSF central region
(amino acid residues 267–468), containing a tandem
repeat of RNA-recognition motifs, did not bind to
DNA, while in contrast, the N-terminal 1–266 fragment
of PSF bound to ssDNA and dsDNA. Therefore, the
N-terminal region of PSF may be the functional domain




The human PSF gene was isolated from a human cDNA
pool by polymerase chain reaction, and was cloned into
the pET-15b vector (Novagen, Darmstadt, Germany).
In this construct, the His6 tag sequence was fused at the
N-terminal end of the gene. The DNA fragments encoding
PSF(1–266) and PSF(267–468) were cloned into the pET-
15b vector. The His6-tagged PSF protein, the His6-tagged
PSF(1–266) mutant and the His6-tagged PSF(267–468)
mutant were each expressed in the Escherichia coli
BL21(DE3) strain, which also carried an expression
vector for the minor tRNAs (Codon(+)RP, Stratagene,
La Jolla, CA, USA). The cells producing the proteins were
resuspended in buﬀer A [50mM Tris-HCl (pH 8.0),
500mM NaCl, 2mM 2-mercaptoethanol and 10% gly-
cerol], and were disrupted by sonication. The cell debris
was removed by centrifugation for 20min at 27700 g,
and the supernatant was mixed gently with 3ml of
Ni–NTA agarose beads (Qiagen, Hilden, Germany) at
48C for 1h. The protein-bound beads were then packed
into an Econo-column (Bio-Rad Laboratories, Hercules,
CA, USA), and were washed with 120ml of buﬀer A,
containing 20mM imidazole. The proteins were eluted
by a 60ml linear gradient of imidazole from 20 to
300mM. The peak fractions were collected, and 2 units
of thrombin protease (GE Healthcare Biosciences,
Uppsala, Sweden) per mg of protein were added to
remove the His6 tag. The samples were immediately dia-
lyzed against buﬀer containing 20mM Tris-HCl (pH 8.0),
200mM NaCl, 0.25mM EDTA, 2mM 2-mercaptoethanol
and 10% glycerol. After removal of the His6 tag, PSF and
PSF(267–468) were loaded onto a 3ml hydroxyapatite
column (Bio-Rad Laboratories, Hercules, CA, USA),
which was immediately eluted with 40ml of buﬀer con-
taining 20mM sodium phosphate (pH 8.0), 200mM NaCl,
0.25mM EDTA, 2mM 2-mercaptoethanol and 10%
glycerol. On the other hand, PSF(1–266) was loaded
onto a 3ml hydroxyapatite column, and the ﬂow through
fractions were collected. PSF was further puriﬁed by
chromatography on a 1.5ml SP-Sepharose column (GE
Healthcare Biosciences, Uppsala, Sweden). The column
was washed with 15ml of buﬀer B [20mM Tris-HCl
(pH 8.5), 0.25mM EDTA, 2mM 2-mercaptoethanol and
10% glycerol] containing 250mM KCl, and PSF was
eluted with a 30ml linear gradient of KCl from 250 to
800mM. PSF(1–266) was dialyzed against buﬀer B con-
taining 100mM KCl, and was further puriﬁed by chroma-
tography on a MonoS column (GE Healthcare
Biosciences, Uppsala, Sweden). The column was washed
with 10ml of buﬀer B containing 100mM KCl and
PSF(1–266) was eluted with 10ml of buﬀer B containing
800mM KCl. PSF(267–468) was dialyzed against buﬀer
B, and was further puriﬁed by chromatography on a
MonoQ column (GE Healthcare Biosciences, Uppsala,
Sweden). The column was washed with 10ml of buﬀer
B, and PSF(267–468) was eluted with a 10ml linear gra-
dient of KCl from 0 to 800mM. PSF, PSF(1–266) and
PSF(267–468) were dialyzed against buﬀer containing
20mM Tris-HCl (pH 8.0), 200mM NaCl, 0.1mM
EDTA, 1mM DTT and 10% glycerol, and were stored
at  808C.
Human RAD51 and human RPA were expressed in
E. coli cells (29,30), and were puriﬁed as described pre-
viously (30–32). The RAD51 used in the present study was
the K313-type isoform, which is highly conserved among
eukaryotes (33).
The DNA fragments encoding the N-terminal domain
(1–114 amino acid residues) and the ATPase domain
(82–339 amino acid residues) of RAD51 were cloned
into the pET-15b vector (Novagen, Darmstadt,
Germany). The His6-tagged N-terminal and ATPase
domains of RAD51 were each expressed in the E. coli
JM109(DE3) strain, which also carried an expression
vector for the minor tRNAs (Codon(+)RIL, Stratagene,
La Jolla, CA, USA). The cells producing the proteins were
resuspended in buﬀer A, containing 5mM imidazole, and
were disrupted by sonication. The cell debris was removed
by centrifugation for 20min at 27700 g, and the
supernatant was mixed gently with 1.5ml of Ni–NTA
agarose beads (Qiagen, Hilden, Germany) at 48C for 1h.
The protein-bound beads were then packed into an
Econo-column (Bio-Rad Laboratories, Hercules, CA,
USA). The RAD51N-terminal domain-bound beads
were washed with 120ml of buﬀer A containing 5mM
imidazole, and the RAD51 ATPase domain-bound
beads were washed with 120ml of buﬀer A containing
30mM imidazole. The RAD51N-terminal domain was
eluted by an 80ml linear gradient of imidazole from 5 to
500mM. The RAD51 ATPase domain was eluted by an
80ml linear gradient of imidazole from 30 to 500mM. The
RAD51N-terminal and ATPase domains were stored at
48C, and were dialyzed before use against 20mM sodium
phosphate buﬀer (pH 8.0), containing 300mM NaCl,
Nucleic Acids Research, 2009,Vol.37, No. 13 42970.1mM EDTA, 2mM 2-mercaptoethanol and 10%
glycerol.
DNA and RNA substrates
In the D-loop formation assay, superhelical dsDNA
(pB5Sarray DNA) was prepared by a method avoiding
alkaline treatment of the cells harboring the plasmid
DNA, to prevent the dsDNA substrates from undergoing
irreversible denaturation. Instead, the cells were gently
lysed using sarkosyl, as described previously (31). The
pB5Sarray DNA contained 11 repeats of a sea urchin 5S
rRNA gene (207-bp fragment) within the pBlueScript
II SK(+) vector. For the ssDNA substrate used in the
D-loop assay, the following high-performance liquid chro-
matography (HPLC)-puriﬁed oligonucleotide was pur-
chased from Nihon Gene Research Laboratory: 50-mer,
50-GGA ATT CGG TAT TCC CAG GCG GTC TCC
CAT CCA AGT ACT AAC CGA GCC CT-30. The 50
ends of the oligonucleotide were labeled with T4 polynu-
cleotide kinase (New England Biolabs, Ipswich, MA,
USA) in the presence of [g-
32P]ATP at 378C for 30min.
Single-stranded fX174 viral (+) strand DNA and double-
stranded fX174 replicative form I DNA were purchased
from New England Biolabs. The linear dsDNA was pre-
pared from the fX174 replicative form I DNA by PstI
digestion. For the strand exchange assay with olignucleo-
tides, the following HPLC-puriﬁed DNA and RNA oligo-
nucleotides were purchased from Nihon Gene Research
Laboratory and Gene Design: 63-mer 50-TCC TTT TGA
TAA GAG GTC ATT TTT GCGGAT GGC TTA GAG
CTT AAT TGC TGA ATC TGG TGCTGT-30,
32-mer top strand, 50-CCA TCC GCA AAA ATG ACC
TCT TAT CAA AAG GA-30,
32-mer bottom strand, 50-TCC TTT TGA TAA GAG
GTC ATT TTT GCG GAT GG-30,
32-mer RNA, 50-UCC UUU UGA UAA GAG GUC
AUU UUU GCG GAU GG-30. The 50 ends of the oligo-
nucleotide (32-mer top strand) were labeled with T4 poly-
nucleotide kinase in the presence of [g-
32P]ATP.
For the pull-down assay with the ssDNA beads, the
following HPLC-puriﬁed 50 biotinylated DNA oligonu-
cleotide was purchased from Nihon Gene Research
Laboratory: 80-mer 50-CTG CTT TAT CAA GAT AAT
TTT TCG ACT CAT CAG AAA TAT CCG AAA GTG
TTA ACT TCT GCG TCA TGG AAG CGA TAA AAC
TC-30. DNA concentrations are expressed in moles
of nucleotides.
The pull-down assay with PSF-conjugated beads
PSF (40mg) was covalently conjugated to Aﬃ-Gel 10 beads
(75ml, Bio-Rad Laboratories, Hercules, CA, USA),
according to the manufacturer’s instructions, and the
Aﬃ-Gel 10-protein matrices were adjusted to 50% slurries.
The His6-tagged RAD51, the His6-tagged RAD51N-term-
inal domain, or the His6-tagged RAD51 ATPase domain
(4mg) was incubated with PSF-conjugated Aﬃ-Gel 10
beads (20ml, 50% slurry) in 100ml of binding buﬀer, con-
taining 20mM sodium phosphate (pH 8.0), 60mM NaCl,
0.1mM EDTA, 2mM 2-mercaptoethanol, 0.05% Triton
X-100 and 10% glycerol. After an incubation at room
temperature for 2.5h, the PSF beads were washed two
times with 100ml of wash buﬀer, containing 20mM
sodium phosphate (pH 8.0), 60mM NaCl, 0.1mM
EDTA, 2mM 2-mercaptoethanol and 10% glycerol. The
proteins bound to the PSF beads were fractionated by 15%
SDS-polyacrylamide gel electrophoresis (PAGE), and the
bandswerevisualizedbyCoomassieBrilliantBluestaining.
The pull-down assay with Ni–NTA beads
Puriﬁed His6-tagged PSF, His6-tagged PSF(1–266), or
His6-tagged PSF(267–468) (3.8mg) was mixed with
RAD51 (7.4mg) in 100ml of binding buﬀer, containing
15mM sodium phosphate (pH 7.5), 95mM NaCl, 5mM
imidazole, 0.21mM EDTA, 2mM 2-mercaptoethanol,
0.025% Triton X-100 and 9% glycerol, and
Ni–NTA agarose beads (3ml, 50% slurry) were then
added. Puriﬁed His6-tagged PSF was also tested with
RPA (10mg) in 100ml of binding buﬀer, containing
15mM sodium phosphate (pH 7.5), 80mM NaCl,
5mM KCl, 5mM imidazole, 0.2mM EDTA, 2mM
2-mercaptoethanol, 0.025% Triton X-100 and 9% gly-
cerol, and then Ni–NTA agarose beads (3ml, 50%
slurry) were added. After an incubation at room temper-
ature for 1h, the beads were washed with 1ml of wash
buﬀer, containing 20mM sodium phosphate (pH 7.5),
100mM NaCl, 0.25mM EDTA, 2mM 2-mercaptoethanol
and 10% glycerol. The proteins bound to the beads and
those in the supernatant were fractionated by 12% SDS–
PAGE, and the bands were visualized by Coomassie
Brilliant Blue staining.
The pull-down assay with the ssDNA beads
PSF (1mM) and RAD51 (5mM) were incubated with mag-
netic streptavidin beads conjugated with the biotinylated
ssDNA 80-mer (16mM) at 378C for 20min, in 10mlo f
reaction buﬀer, containing 28mM Tris-HCl (pH 8.0),
4mM HEPES-NaOH (pH 7.5), 110mM NaCl, 0.06mM
EDTA, 0.4mM 2-mercaptoethanol, 6% glycerol, 1mM
MgCl2, 1.4mM DTT and 1mM ATP. After an incuba-
tion, the beads were washed with 10ml of reaction buﬀer.
The proteins bound to the beads were fractionated
by 12% SDS–PAGE, and the bands were visualized by
Coomassie Brilliant Blue staining.
The D-loop formation assay
PSF and RAD51 were incubated with the
32P-labeled
50-mer oligonucleotide (1mM) at 378C for 10min, in 7ml
of reaction buﬀer, containing 24mM Tris-HCl (pH 8.0),
2.0mM HEPES-NaOH (pH 7.5), 55mM NaCl, 0.03mM
EDTA, 0.2mM 2-mercaptoethanol, 3% glycerol, 1mM
MgCl2, 1.2mM DTT, 2mM AMPPNP and 0.1mg/ml
BSA. The reactions were then initiated by the addition
of the pB5Sarray superhelical dsDNA (30mM) along
with 9mM MgCl2, and were continued at 378C for
30min. The reactions were stopped by the addition of
0.2% SDS and 1.5mg/ml proteinase K (Roche Applied
Science, Basel, Switzerland), and were further incubated
at 378C for 15min. After adding six-fold loading dye,
the deproteinized reaction products were separated by
1% agarose gel electrophoresis in 1 TAE buﬀer at
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imaging plate, and visualized using an FLA-7000 imaging
analyzer (Fujiﬁlm, Tokyo, Japan).
The strand-exchange assay
The fX174 circular ssDNA (20mM), RAD51 (0.5–
6.6mM) and RPA (1.3mM) were incubated with or
without PSF (1.0mM) at 378C for 10min, in the reac-
tion buﬀer, containing 30mM Tris-HCl (pH 8.0),
95mM NaCl, 5mM KCl, 0.05mM EDTA, 0.2mM
2-mercaptoethanol, 6% glycerol, 1mM MgCl2,1 m M
CaCl2, 1.5mM DTT, 1mM ATP, 0.1mg/ml BSA,
20mM creatine phosphate and 75mg/ml creatine kinase.
The reactions were then initiated by the addition of fX174
linear dsDNA (20mM), and were continued at 378C. At
the indicated times, a 10ml aliquot of the reaction mixture
was mixed with 0.2% SDS and 1.5mg/ml proteinase K to
stop the reaction, and was further incubated at 378C for
15min. After adding six-fold loading dye, the deprotei-
nized reaction products were separated by 1% agarose
gel electrophoresis in 1 TAE buﬀer at 3.3V/cm for 4h.
The products were visualized by SYBR Gold (Invitrogen,
Carlsbad, CA, USA) staining.
The strand-exchange assay with oligonucleotides
RAD51 (3mM) and the indicated amount of PSF
were incubated with a 63-mer ssDNA (15mM) at 378C
for 10min, in 10ml of reaction buﬀer, containing
28mM Tris-HCl (pH 8.0), 4mM HEPES-NaOH
(pH 7.5), 110mM NaCl, 0.06mM EDTA, 0.4mM
2-mercaptoethanol, 6% glycerol, 1mM MgCl2,1 m M
CaCl2, 1.4mM DTT, 1mM ATP, 0.1mg/ml BSA,
20mM creatine phosphate and 75mg/ml creatine kinase.
The reactions were initiated by the addition of the 32-mer
dsDNA or RNA/DNA hybrid (1.5mM), which shared
sequence homology with the 63-mer ssDNA. The 32-mer
dsDNA and the RNA/DNA hybrid used in this assay
were puriﬁed by polyacrylamide gel electrophoresis.
After a 30min incubation at 378C, the reaction was
stopped by the addition of 0.2% SDS and 1.5mg/ml
proteinase K, and was further incubated at 378C for
15min. After six-fold loading dye was added, the reaction
mixtures were subjected to 15% polyacrylamide gel elec-
trophoresis in 0.5 TBE buﬀer (45mM Tris, 45mM boric
acid and 1mM EDTA) at 10V/cm for 4h. The gels were
dried, exposed to an imaging plate, and visualized using
an FLA-7000 imaging analyzer.
The DNA-binding assay
The fX174 circular ssDNA (20mM) or the linearized
fX174 dsDNA (20mM) was mixed with the indicated
amount of PSF, PSF(1–266) or PSF(267–468) in 10mlo f
a standard reaction solution, containing 30mM Tris–HCl
(pH 8.0), 1.5mM DTT, 100mM NaCl, 1mM MgCl2,5 %
glycerol and 0.1mg/ml BSA. The reaction mixtures were
incubated at 378C for 10min, and were then separated by
0.8% agarose gel electrophoresis in 1 TAE buﬀer (40mM
Tris-acetate and 1mM EDTA) at 3.3V/cm for 2.5h. The
bands were visualized by ethidium bromide staining.
MALDI-TOF-MS analysis
A2ml aliquot of 5% triﬂuoroacetic acid (TFA) was added
to 18ml of a 0.4mg/ml PSF solution, or 1ml of 5% TFA
was added to 9ml of a 1.0mg/ml PSF(1–266) or 1.3mg/ml
PSF(267–468) sample, and the mixture was bound to a
ZipTip (C4) pipette tip (Millipore, Billerica, MA, USA).
After the protein was bound, the tip was ﬁrst rinsed with
0.1% TFA and 5% methanol, and then rinsed with 0.1%
TFA. PSF, PSF(1–266), or PSF(267–468) was eluted with
0.1% TFA and 80% acetonitrile, and was deposited onto
the sample plate, which was precoated with a dried layer
of sinapic acid (Sigma-Aldrich, St Louis, MO, USA). A
MALDI-TOF mass spectrometry analysis was performed
with an AXIMA-CFR mass spectrometer (Kratos
Analytical, Manchester, UK). Bovine carbonic anhydrase
II and BSA were used as standard proteins for external
calibration. Each single spectrum was obtained as an
accumulation of 50 laser shots.
RESULTS
Human PSF binds to RAD51
To test whether PSF binds to RAD51, we performed
pull-down assays with the PSF-conjugated beads. To pre-
pare the PSF beads, human PSF was expressed in E. coli
cells as a His6-tagged protein, and was puriﬁed by chro-
matography on a Ni-NTA agarose column (Figure 1A,
lane 4). The His6 tag was removed by thrombin protease
treatment (Figure 1B), and the protein was further puri-
ﬁed by chromatography on a hydroxyapatite and
SP-Sepharose columns (Figure 1A, lanes 5 and 6). The
puriﬁed PSF was conjugated to Aﬃ-Gel 10 beads, and
RAD51 binding to the PSF beads was tested by the
pull-down assay. As shown in Figure 1C (lane 5), substan-
tial amounts of RAD51 were associated with the PSF
beads, indicating that PSF directly binds to RAD51.
Structural studies revealed that RAD51 is composed of
two distinct domains, the N-terminal and ATPase
domains (34–38). To identify the PSF-binding domain of
RAD51, we prepared two RAD51 fragments, amino
acid residues 1–114 and 82–339, which contained the
N-terminal and ATPase domains, respectively
(Figure 1C, lanes 3 and 4). The pull-down assay revealed
that the ATPase domain of RAD51 bound to PSF with
the almost same eﬃciency as the full-length RAD51
(Figure 1C, lane 9). In contrast, the RAD51N-terminal
fragment containing amino acid residues 1–114 did not
show signiﬁcant binding to PSF (Figure 1C, lane 7).
These results indicate that PSF directly binds to the
ATPase domain of RAD51.
The PSF–RAD51 binding was also detected by the
Ni-bead pull-down assay with His6-tagged PSF
(Figure 1D, lane 8). In contrast, PSF did not bind to
RPA (Figure 1D, lane 5), suggesting that the PSF–
RAD51 interaction is speciﬁc. The Ni-bead pull-down
assay, in which all of the proteins could be visualized on
the SDS–PAGE gel, allowed us to estimate the binding
stoichiometry between PSF and RAD51. As shown in
Figure 1E, His6-tagged PSF copelleted RAD51 in a
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the amount of free RAD51 in the supernatant was also
reduced in the presence of His6-tagged PSF (Figure 1F
and G). The PSF–RAD51 binding stoichiometry was
about 1:1, in the presence of an excess of RAD51
(Figure 1E, lane 8).
PSF modulates homologous pairing by RAD51
We next tested the eﬀect of PSF in the RAD51-mediated
homologous pairing. PSF reportedly promotes the
formation of D-loops (28), which are the products of the
homologous pairing reaction between ssDNA fragments
and superhelical dsDNA. Therefore, we performed the
D-loop formation assay (Figure 2A). The superhelical
dsDNA used in this assay was prepared by a method with-
out alkali treatment, to avoid denaturation of the double
helix of the dsDNA (31). Consistent with the previous
observations, PSF or RAD51 alone promoted homolo-
gous pairing (Figure 2B, lanes 2–6, and 2C) (28). When
PSF and a low amount of RAD51 (0.1mM) were present
Figure 1. Human PSF binds to RAD51. (A) Puriﬁcation of human PSF. Proteins from each puriﬁcation step were analyzed by 12% SDS–PAGE
with Coomassie Brilliant Blue staining. Lane 1 indicates the molecular mass markers. Lanes 2 and 3 are the whole cell lysates before and after
induction with isopropyl-1-thio--D-galactopyranoside, respectively. Lanes 4–6 indicate the samples from the peak Ni–NTA agarose fraction, the
peak hydroxyapatite fraction, and the peak SP-Sepharose fraction. (B) A 6% SDS–PAGE image of the Ni–NTA agarose fraction before (lane 2)
and after (lane 3) the removal of the hexahistidine tag. (C) Pull-down assay with the PSF-conjugated beads. Proteins bound to the PSF-conjugated
beads were analyzed by 15% SDS–PAGE with Coomassie Brilliant Blue staining. Lane 1 indicates the molecular mass markers. Lanes 2–4 represent
His6-tagged RAD51, His6-tagged RAD51(1–114), and His6-tagged RAD51(82–339), respectively. Lanes 5 and 6 indicate experiments with RAD51
with the PSF-conjugated beads and the Aﬃ-Gel 10 beads, respectively. Lanes 7 and 8 indicate experiments with His6-tagged RAD51(1–114) with the
PSF-conjugated beads and the Aﬃ-Gel 10 beads, respectively. Lanes 9 and 10 indicate experiments with His6-tagged RAD51(82–339) with the PSF-
conjugated beads and the Aﬃ-Gel 10 beads, respectively. (D) Pull-down assay with the Ni–NTA agarose beads. Proteins bound to His6-tagged PSF
were captured by the Ni–NTA agarose beads, and were analyzed by 15% SDS–PAGE with Coomassie Brilliant Blue staining. In the Ni–NTA pull-
down assay, RPA and RAD51 did not contain His6-tags. Lane 1 indicates the molecular mass markers. Lanes 2, 3 and 6 represent His6-tagged PSF,
RPA and RAD51, respectively. Lanes 4 and 5 indicate experiments with RPA in the absence and presence of His6-tagged PSF, respectively. Lanes 7
and 8 indicate experiments with RAD51 in the absence and presence of His6-tagged PSF, respectively. (E) The RAD51-titration experiments.
Proteins bound to His6-tagged PSF were captured by the Ni–NTA agarose beads, and were analyzed by 15% SDS–PAGE with Coomassie
Brilliant Blue staining. Lane 1 indicates the molecular mass markers. Lanes 2 and 3 represent RAD51 and His6-tagged PSF, respectively. Lanes
4–8 and 9–13 indicate experiments in the presence and absence of His6-tagged PSF, respectively. RAD51 were 1mg (lanes 4 and 9), 2mg (lanes 5 and
10), 3mg (lanes 6 and 11), 4mg (lanes 7 and 12), and 5mg (lanes 8 and 13). (F) Supernatant fractions of the experiments shown in panel E were
analyzed by 15% SDS–PAGE with Coomassie Brilliant Blue staining. Lane numbers correspond to those in panel E. (G) Graphic representation
of the experiments shown in panel F. Average relative intensities of the RAD51 bands from three independent experiments are represented with the
SD values.
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centration-dependent manner (Figure 2B, lanes 7–10, and
Figure 2C). This stimulation of D-loop formation was
not observed when the reactions were conducted in the
absence of an ATP analog, AMPPNP, which was required
for the RAD51-mediated D-loop formation, but not for
the PSF-mediated D-loop formation (Figure 2D).
Therefore, PSF may function as an activator for RAD51
in homologous pairing under low RAD51 conditions.
In contrast to the PSF-mediated homologous-pairing
activation in the presence of 0.1mM RAD51, PSF signiﬁ-
cantly inhibited the RAD51-mediated homologous pair-
ing, when the reaction was conducted in the presence of
RAD51 concentrations above 0.35mM, which are optimal
for the reaction without PSF. As shown in Figure 2E and
F, PSF stimulated the RAD51-mediated homologous
pairing in the presence of 0.05 and 0.1mM RAD51
(compare lane 2 with lane 8, and lane 3 with lane 9).
In contrast, PSF inhibited the homologous pairing in the
presence of 0.35 and 0.7mM RAD51 (Figure 2E, compare
lane 5 with lane 11, and lane 6 with lane 12, and
Figure 2F). These results indicated that PSF stimulates
homologous pairing in the presence of a suboptimal
concentration of RAD51, but inhibits the reaction in the
presence of an optimal concentration of RAD51.
PSF modulates RAD51-mediated strand exchange
We next tested whether PSF aﬀects strand exchange by
RAD51 (Figure 3A). To evaluate the activator function of
PSF in the RAD51-mediated strand exchange, we ﬁrst
performed the strand-exchange assay with a suboptimal
concentration of RAD51 (0.5mM). Under these reaction
conditions, a small amount of joint molecule (JM) product
was detected in the absence of PSF in the 30, 60 and
90min reactions (Figure 3B, lanes 5, 7 and 9, and
Figure 2. Human PSF stimulates the RAD51-mediated homologous pairing. (A) A schematic diagram of the D-loop formation assay. Asterisks
indicate the
32P-labeled end of the 50-mer ssDNA. (B) The D-loop formation assay with AMPPNP. The reactions were conducted without RAD51
(lanes 1–5) or with 0.1mM RAD51 (lanes 6–10) in the presence of increasing amounts of PSF. The PSF concentrations were 0mM (lanes 1 and 6),
0.125mM (lanes 2 and 7), 0.25mM (lanes 3 and 8), 0.5mM (lanes 4 and 9), and 1.0mM (lanes 5 and 10). (C) Graphic representation of the experiments
shown in panel B. The average values of three independent experiments are shown with the SD values. Closed and open circles represent the
experiments with and without RAD51, respectively. (D) The D-loop formation assay without AMPPNP. The reactions were conducted without
RAD51 (lanes 1–3) or with 0.1mM RAD51 (lanes 4–6) in the presence of increasing amounts of PSF. The PSF concentrations were 0mM (lanes 1
and 4), 0.25mM (lanes 2 and 5) and 0.5mM (lanes 3 and 6). (E) The RAD51-titration experiments of the D-loop formation assay with AMPPNP.
Lane 1 indicates a negative control experiment without RAD51 and PSF, and lane 7 indicates a control experiment without RAD51 in the presence
of PSF. Lanes 2–6 and 7–12 indicate experiments in the absence and presence of PSF, respectively. The reactions were conducted with 0.5mM PSF
(lanes 7–12). The RAD51 concentrations were 0.05mM (lanes 2 and 8), 0.1mM (lanes 3 and 9), 0.2mM (lanes 4 and 10), 0.35mM (lanes 5 and 11) and
0.7mM (lanes 6 and 12). (F) Graphic representation of the experiments shown in panel E. The average values of three independent experiments are
shown with the SD values. Closed and open circles represent the experiments with and without PSF, respectively.
Nucleic Acids Research, 2009,Vol.37, No. 13 4301Figure 3C). In contrast to the D-loop formation, PSF
itself did not promote strand exchange (Figure 3B, lane
11, and Figure 3C). When PSF was added to the reaction
mixture, the amount of the JM products formed by the
RAD51-mediated strand exchange signiﬁcantly increased
(Figure 3B, lanes 4, 6, 8 and 10, and Figure 3C). These
results indicated that PSF stimulates the RAD51 strand-
exchange activity, as well as the homologous-pairing
stimulating activity, in the presence of a suboptimal
concentration of RAD51. This RAD51 activation by
PSF was not observed when the strand-exchange reactions
were performed without Ca
2+, which stabilizes the
RAD51–ssDNA ﬁlament by inhibiting ATP hydrolysis
(39) (Figure 3D).
Under the reaction conditions with Ca
2+, a 2–4mM
RAD51 concentration was optimal for strand exchange
without PSF (Figure 3E, lanes 7 and 9 and Figure 3F).
Consistent with the results from the D-loop formation
assay, PSF inhibited the RAD51-mediated strand
exchange in the presence of an optimal RAD51 concen-
tration, although it stimulated the reactions under low
RAD51 conditions (0.5 and 1.0mM RAD51) (Figure 3E
and F). Therefore, PSF functions as activator or inhibitor
of the homologous-pairing and strand-exchange activities
of RAD51, in a RAD51 concentration-dependent manner.
We then tested whether the order of the PSF addition
aﬀected the strand-exchange stimulation in the presence of
the low RAD51 concentration (0.5mM). As shown in
Figure 3B and C, when PSF, RAD51, RPA and ssDNA
were co-incubated together before initiating the reaction
by the addition of dsDNA, the strand-exchange
reaction was signiﬁcantly enhanced (Figure 4A, lanes
Figure 3. Human PSF stimulates the RAD51-mediated strand exchange. (A) A schematic representation of the strand-exchange reaction. The joint
molecule product is denoted as JM. (B) The fX174 circular ssDNA (20mM), RAD51 (0.5mM) and RPA (1.3mM) were incubated with or without
PSF (1.0mM) at 378C for 10min. After this incubation, the reactions were then initiated by the addition of fX174 linear dsDNA (20mM), and were
continued at 378C for the indicated times. The deproteinized products were separated by 1% agarose gel electrophoresis, and were visualized by
SYBR Gold staining. The asterisk indicates the self-annealing products of the ssDNA. Lanes 1, 3, 5, 7 and 9 indicate control experiments without
PSF. Lanes 2, 4, 6, 8 and 10 indicate experiments with PSF. Lane 11 indicates a negative control experiment with PSF in the absence of RAD51.
(C) Graphic representation of the strand-exchange experiments shown in panel B. The band intensities of the JM products were quantiEed, and the
average values of three independent experiments are shown with the SD values. Closed and open circles represent the experiments with and without
PSF, respectively. Closed triangles represent the experiments with PSF in the absence of RAD51. (D)C a
2+ requirement. The strand-exchange
reactions were conducted with or without Ca
2+, and were performed according to the same procedure as shown in panel B. The reaction time was
60min. Lane 1 indicates a negative control experiment without proteins. Lanes 2 and 3 indicate experiments without and with PSF, respectively, in
the presence of CaCl2. Lanes 4 and 5 indicate experiments without and with PSF, respectively, in the absence of CaCl2.( E) The RAD51-titration
experiments. The strand-exchange reactions were conducted with Ca
2+, and were performed according to the same procedure as shown in panel B.
The reaction time was 60min. Lanes 2, 4, 6, 8, 10 and 12 indicate experiments with 1mM PSF, and lanes 1, 3, 5, 7, 9 and 11 indicate experiments
without PSF. The RAD51 concentrations were 0mM (lanes 1 and 2), 0.5mM (lanes 3 and 4), 1mM (lanes 5 and 6), 2mM (lanes 7 and 8), 4mM (lanes
9 and 10) and 6.6mM (lanes 11 and 12). (F) Graphic representation of the strand-exchange experiments shown in panel E. The band intensities of the
JM products were quantiEed, and the average values of three independent experiments are shown with the SD values. Closed and open circles
represent the experiments with and without PSF, respectively.
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exchange, when it was incubated with ssDNA before
RAD51 addition (Figure 4A, lanes 4 and 5, Figure 4B
and C). Enhancement of strand exchange was also
observed when PSF and RPA were added after the
RAD51–ssDNA incubation (Figure 4A, lanes 6–9, and
Figure 4D–G). These results suggested that, under low
RAD51 conditions, PSF stimulates strand exchange by
RAD51, when it was added after the RAD51–ssDNA ﬁl-
ament formation. Since PSF inhibited strand exchange in
the presence of an optimal amount of RAD51 (high
RAD51 conditions), where RAD51 covered most of the
ssDNA, PSF may bind to the RAD51-free ssDNA region
under low RAD51 conditions and function as a RAD51
mediator.
PSF competes with RAD51 for ssDNA binding
Under the high RAD51 conditions, PSF inhibited homol-
ogous pairing and strand exchange by RAD51, suggesting
that PSF may compete with RAD51 for ssDNA binding.
To test this possibility, we prepared streptavidin beads
conjugated with a biotinylated ssDNA 80-mer, and per-
formed a pull-down assay with these ssDNA beads
(Figure 5A). As shown in Figure 5B (lanes 4 and 6) and
5C, RAD51 or PSF bound to the ssDNA beads. However,
the amount of RAD51 bound to the ssDNA beads was
signiﬁcantly decreased, when both RAD51 and PSF were
coincubated with the ssDNA beads (Figure 5B, lane 5,
and Figure 5C). This inhibition of the RAD51–ssDNA
binding by PSF was also observed when PSF was added
to the ssDNA beads before and after RAD51 (Figure 5B,
lanes 7–12, and Figure 5C). Therefore, we concluded that
the PSF-dependent inhibition of homologous pairing and
strand exchange, in the presence of an optimal amount of
RAD51, may be due to RAD51 disassembly from the
ssDNA by PSF. PSF may not disassemble RAD51 from
ssDNA, when a RAD51-free ssDNA region is available
for PSF–ssDNA binding, under the low RAD51
conditions.
PSF promotes strand exchange between ssDNA and an
RNA/DNA hybrid
PSF contains RNA-binding motifs, and is known to
be involved in transcription (20–24), suggesting that
PSF may be involved in a transcription-associated Figure 4. Eﬀects of the PSF reaction order on RAD51-mediated strand
exchange. The fX174 circular ssDNA (20mM), RAD51 (0.5mM), RPA
(1.3mM) and PSF (1.0mM) were incubated at 378C in various combi-
nations. After this incubation, the reactions were then initiated by the
addition of fX174 linear dsDNA (20mM), and were continued at 378C
for the indicated times. The deproteinized products were separated by
1% agarose gel electrophoresis, and were visualized by SYBR Gold
staining. (A) The proteins and ssDNA were incubated in the combina-
tions represented on the right side of panel A. Lane 1 indicates a neg-
ative control experiment without proteins. Lanes 2, 4, 6 and 8 indicate
control experiments without PSF, and lanes 3, 5, 7 and 9 indicate
experiments with PSF. The reaction time was 60min. (B) The fX174
circular ssDNA was incubated with PSF at 378C for 10min. After this
incubation, RAD51 was added to the reaction mixture, which was
incubated at 378C for 5min. RPA was then added, and the reactions
were initiated by the addition of fX174 linear dsDNA. Reactions were
continued for the indicated times. (C) Graphic representation of the
strand-exchange experiments shown in panel B. The band intensities
of the JM products were quantiEed. Closed and open circles represent
the experiments with and without PSF, respectively. (D) The fX174
circular ssDNA was incubated with RAD51at 378C for 10min. After
this incubation, PSF was added to the reaction mixture, which was
incubated at 378C for 5min. RPA was then added, and the reactions
were initiated by the addition of fX174 linear dsDNA. Reactions were
continued for the indicated times. (E) Graphic representation of the
strand-exchange experiments shown in panel D. The band intensities
of the JM products were quantiEed. Closed and open circles represent
the experiments with and without PSF, respectively. (F) The fX174
circular ssDNA was incubated with RAD51at 378C for 10min. After
this incubation, RPA was added to the reaction mixture, which was
incubated at 378C for 5min. PSF was then added, and the reactions
were initiated by the addition of fX174 linear dsDNA. Reactions were
continued for the indicated times. (G) Graphic representation of the
strand-exchange experiments shown in panel F. The band intensities of
the JM products were quantiEed. Closed and open circles represent the
experiments with and without PSF, respectively.
Nucleic Acids Research, 2009,Vol.37, No. 13 4303recombination event. Therefore, we tested whether PSF
aﬀects strand exchange between ssDNA and an RNA/
DNA hybrid, which may be formed when transcription
stalls. To do so, we performed a strand exchange assay
with short oligonucleotides (Figure 6A). In this assay, the
32-mer dsDNA and RNA/DNA hybrid were puriﬁed
by polyacrylamide gel electrophoresis. Consistent with
the results from the D-loop formation assay and
the strand-exchange assay with long DNA substrates,
PSF stimulated the RAD51-mediated strand exchange
with oligonucleotides under the suboptimal RAD51
conditions. We found that RAD51 promoted strand
exchange between ssDNA and an RNA/DNA hybrid
(Figure 6B and C). Intriguingly, PSF also stimulated
this reaction (Figure 6B and C). Therefore, PSF has
the potential to function in transcription-associated
recombination.
Domain analysis of PSF
To identify the functional domains of PSF, we constructed
three PSF deletion mutants, PSF(1–266), PSF(267–468)
and PSF(469–707), which were composed of amino acid
residues 1–266, 267–468 and 469–707, respectively
(Figure 7A). These PSF deletion mutants were expressed
in E. coli cells, and PSF(1–266) and PSF(267–468) were
successfully obtained in the soluble fractions. However,
PSF(469–707) was only found in the insoluble fraction,
suggesting that it did not fold properly. Therefore, we
puriﬁed PSF(1–266) and PSF(267–468) as recombinant
proteins (Figure 7B). The puriﬁed PSF deletion mutants
did not contain the His6 tag. The predicted molecular
masses of PSF, PSF(1–266), and PSF(267–468) are 76,
26 and 23kDa, respectively. However, PSF, PSF(1–266)
and PSF(267–468) migrated on an SDS-denaturing
polyacrylamide gel with distances corresponding
to about 100, 42 and 25kDa, respectively (Figure 7B).
A mass spectrometric analysis revealed that the molecular
masses of puriﬁed PSF, PSF(1–266), and PSF(267–468)
were 76, 26 and 23kDa, respectively. Therefore, the
abnormal migrations of PSF and PSF(1–266) on the
SDS-denaturing polyacrylamide gel may be a consequence
of their basic pI values, 9.45 and 12.01, respectively.
As previously reported by Akhmedov and Lopez (28),
PSF bound to ssDNA and dsDNA (Figure 8A and B,
lanes 2–4). PSF(1–266) also bound to both ssDNA and
dsDNA (Figure 8A and B, lanes 5–7). In contrast,
PSF(267–468), which contains RNA recognition motifs,
did not bind either ssDNA or dsDNA under these reac-
tion conditions (Figure 8A and B, lanes 8–10). Therefore,
the DNA- and RNA-binding domains are separately
located in the N-terminal and central domains of PSF,
respectively.
We next tested the RAD51-binding activity of
PSF(1–266) and PSF(267–468). To do so, we prepared
the His6-tagged PSF, PSF(1–266) and PSF(267–468) pro-
teins (Figure 8C, lanes 3–5), and performed a pull-down
assay with the Ni–NTA agarose beads. Consistent with the
results from the pull-down assay by the PSF-conjugated
beads (Figure 1C), His6-tagged PSF also bound to
RAD51 in the Ni–NTA pull-down assay (Figure 8C, lane
7). A substantial amount of RAD51 was pulled down with
His6-tagged PSF(1–266) (Figure 8C, lane 8), but not with
His6-tagged PSF(267–468) (Figure 8C, lane 9). Therefore,
the N-terminal 1–266 region of PSF contains both the
DNA- and RAD51-binding sites.
DISCUSSION
Previous studies have suggested that PSF is a multifunc-
tional nuclear protein, which functions in RNA synthesis,
RNA processing, RNA transport, and transcription (40).
In addition to these functions, interestingly, PSF was
Figure 5. PSF competes with RAD51 for ssDNA binding. (A) A schematic representation of the ssDNA bead pull-down assay. (B) RAD51 (5mM)
and PSF (1mM) were incubated with the ssDNA (16mM) beads, and the proteins bound to the ssDNA were analyzed by 15% SDS–PAGE with
Coomassie Brilliant Blue staining. Lane 1 indicates the molecular mass markers. Lane 5 indicates an experiment in which RAD51, PSF, and the
ssDNA beads were simultaneously incubated. Lane 8 indicates an experiment in which RAD51 and the ssDNA beads were incubated before the
addition of PSF. Lane 11 indicates an experiment in which PSF and the ssDNA beads were incubated before the addition of RAD51. Lanes 2 and 3
represent PSF and RAD51, respectively. Lanes 4, 7 and 10 indicate control experiments without PSF, and lanes 6, 9 and 12 indicate control
experiments without RAD51. (C) Graphic representation of the ssDNA bead pull-down assay shown in panel B. The RAD51 band intensities were
quantiEed, and the average values of three independent experiments are shown with the SD values.
4304 Nucleic Acids Research, 2009, Vol. 37,No. 13puriﬁed from a HeLa cell extract as a protein that pro-
motes homologous pairing between ssDNA and dsDNA
in vitro (28). This ﬁnding suggested that PSF may also
function in homologous recombination, and prompted
us to test whether PSF aﬀects the recombination activity
of RAD51, which is a central protein for homologous
recombination in eukaryotes.
In the present study, we puriﬁed human PSF as a
recombinant protein, and found that PSF directly
binds to RAD51. Interestingly, PSF stimulates
RAD51-mediated homologous pairing and strand
exchange at low RAD51 concentrations, but inhibits
these reactions at high RAD51 concentrations, which
are optimal for the reactions without PSF. These ﬁndings
suggest that PSF may be a novel recombination factor,
which has both activator and suppressor functions for
the RAD51 recombinase activity. During the initial
period of homologous recombination in cells, PSF may
function as activator, perhaps because the RAD51 accu-
mulation at the recombination sites is not yet suﬃcient.
The RAD51 concentration at the recombination sites is
supposed to increase during the homologous recombina-
tion processes. Excess RAD51 accumulation on chromo-
somes at later stages of homologous recombination may
induce undesired recombination, which may cause the
chromosomal aberrations frequently found in tumor
cells. PSF may then function as an inhibitor of RAD51,
to suppress such inappropriate recombination reactions
by removing RAD51 from ssDNA during homologous
recombination. We found that PSF competes with
RAD51 for ssDNA binding, and removes RAD51 from
ssDNA. This fact indicated that PSF does not form a
three-component complex with RAD51 and ssDNA,
although the PSF–RAD51 complex is formed in the
absence of ssDNA. Therefore, PSF may be recruited to
the recombination sites as a complex form with RAD51,
and may be released from RAD51 to free the ssDNA
region when RAD51 is assembled on the recombination
site.
We and others found that PSF alone (i) binds to ssDNA
and dsDNA, (ii) promotes D-loop formation between
ssDNA and dsDNA, and (iii) anneals complementary
ssDNAs (28). In this study, we also found that (iv) the
N-terminal domain of PSF directly binds to the central
ATPase domain of RAD51, and (v) PSF modulates the
RAD51-mediated homologous pairing and strand
exchange reactions. These biochemical characteristics of
PSF partially overlap with those of RAD52, which is
an important activator for RAD51 (7–10). In the
yeast Saccharomyces cerevisiae, the rad52 mutation
reportedly exhibits signiﬁcant sensitivity to DSB inducing
agents, such as ionizing radiation (41,42). However, the
Figure 6. The strand-exchange assay between the ssDNA 63-mer and
either the dsDNA 32-mer or the RNA/DNA hybrid 32-mer. (A)A
schematic representation of the strand-exchange assay with oligonucleo-
tides. Asterisks indicate the
32P-labeled end of the ssDNA 32-mer,
which is complementary to the ssDNA 63-mer. The dsDNA and
RNA/DNA hybrid 32-mers were prepared by anealing the
32P-labeled
ssDNA strand with the complementary ssDNA 32-mer or the comple-
mentary RNA 32-mer, and were puriﬁed by native polyacrylamide gel
electrophoresis. (B) The strand-exchange assay. The ssDNA 63-mer
(15mM) was incubated with RAD51 (3mM) in the presence of the
indicated amounts of PSF. The reactions were initiated by adding
dsDNA (lanes 1–6) or the RNA/DNA hybrid (lanes 7–12). The
strand-exchange products were analyzed by 15% native polyacrylamide
gel electrophoresis. Lanes 1 and 7 indicate negative control experiments
without proteins. Lanes 6 and 12 indicate control experiments without
RAD51 in the presence of 2mM PSF. The PSF concentrations were
0mM (lanes 2 and 8), 0.5mM (lanes 3 and 9), 1mM (lanes 4 and 10)
and 2mM (lanes 5 and 11). (C) Graphic representation of the strand-
exchange assay shown in panel B. The average values of three indepen-
dent experiments are shown with the SD values. Lane numbers
correspond to those in panel B.
Figure 7. Puriﬁcation of the PSF deletion mutants. (A) Schematic rep-
resentation of human PSF. P/Q and P indicate the proline/glutamine-
rich and proline-rich domains, respectively. RRM1 and RRM2 indicate
the RNA-recognition motifs 1 and 2, respectively. Arrows represent
regions corresponding to the deletion mutants. (B) The puriﬁed PSF,
PSF(1–266), and PSF(267–468) proteins were analyzed by 15% SDS–
PAGE with Coomassie Brilliant Blue staining. These proteins did not
contain a His6 tag.
Nucleic Acids Research, 2009,Vol.37, No. 13 4305RAD52-knockout chicken DT40 cells did not show signif-
icant defects in DSB repair (43). This discrepancy may
explain the functional redundancy of RAD52 with other
factors in higher eukaryotes (44). PSF may share a
common function with RAD52 in vertebrates.
PSF was also puriﬁed from a nuclear extract of HeLa
cells, as a complex form with p54(nrb). Intriguingly, the
PSF–p54(nrb) complex stimulated a non-homologous
DNA end joining (NHEJ) reaction by Ku70/80, DNA
ligase IV and XRCC4 (27). NHEJ is a rapid, error-prone
DSB repair pathway. On the other hand, homologous-
recombinational repair (HRR) is an accurate, error-free
DSB repair pathway. The present study has provided new
evidence that PSF physically and functionally interacts
with RAD51, which is the central enzyme for the homolo-
gous recombination reactions. Therefore, PSF may be
involved in both DSB repair pathways, NHEJ and HRR,
with diﬀerent partners, p54(nrb) and RAD51, respectively.
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